HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Ali Calderon-Aparicio Selected Research
Ali Calderon-Aparicio Research Topics
Disease
6
Neoplasms (Cancer)
12/2021 - 10/2015
2
Melanoma (Melanoma, Malignant)
01/2019 - 10/2015
1
Prostatic Neoplasms (Prostate Cancer)
12/2021
1
Neoplasm Metastasis (Metastasis)
12/2021
1
Colonic Neoplasms (Colon Cancer)
12/2020
1
Esophageal Neoplasms (Esophageal Cancer)
11/2020
1
Colorectal Neoplasms (Colorectal Cancer)
01/2019
1
Breast Neoplasms (Breast Cancer)
10/2015
Drug/Important Bio-Agent (IBA)
2
Transcription Factors (Transcription Factor)
IBA
02/2021 - 11/2020
2
tetrathiomolybdate (ammonium tetrathiomolybdate)
IBA
01/2019 - 10/2015
2
Disulfiram (Antabuse)
FDA Link
01/2019 - 10/2015
2
Chelating Agents
IBA
01/2019 - 10/2015
2
Copper
IBA
01/2019 - 10/2015
1
Proteome
IBA
12/2021
1
Messenger RNA (mRNA)
IBA
12/2021
1
Biomarkers (Surrogate Marker)
IBA
02/2021
1
ERRalpha Estrogen-Related Receptor
IBA
12/2020
1
SOXB1 Transcription Factors
IBA
11/2020
1
Proteins (Proteins, Gene)
FDA Link
11/2020
1
neocuproine
IBA
01/2019
1
Mitogen-Activated Protein Kinase Kinases (MEKs)
IBA
01/2019
1
Enzymes
IBA
01/2019
1
Oxaliplatin (Eloxatin)
FDA Link
Generic
01/2019
1
U 0126 (UO 126)
IBA
01/2019
1
1,10-phenanthroline
IBA
01/2019
1
Reactive Oxygen Species (Oxygen Radicals)
IBA
10/2015
Therapy/Procedure
3
Therapeutics
12/2021 - 01/2019
1
Radiotherapy
02/2021
1
Drug Therapy (Chemotherapy)
02/2021